相似文献
1
Inhibition of aldehyde reductase by acidic metabolites of the biogenic amines.生物胺的酸性代谢产物对醛还原酶的抑制作用。
Biochem Pharmacol. 1975 Sep 15;24(18):1731-3. doi: 10.1016/0006-2952(75)90016-7.
2
Enzymatic reduction of "biogenic" aldehydes in brain.大脑中“生物源”醛类的酶促还原作用。
Mol Pharmacol. 1973 Jul;9(4):428-37.
3
Alcohol, aldehydes, and biogenic amines.酒精、醛类和生物胺。
Ann N Y Acad Sci. 1973 Apr 30;215:84-8. doi: 10.1111/j.1749-6632.1973.tb28252.x.
4
Role of aldehyde oxidase in biogenic amine metabolism.醛氧化酶在生物胺代谢中的作用。
Prog Brain Res. 1995;106:345-53. doi: 10.1016/s0079-6123(08)61230-3.
5
Reduction of biogenic aldehydes by aldehyde reductase and alcohol dehydrogenase from human liver.人肝脏中醛还原酶和乙醇脱氢酶对生物源醛的还原作用。
Biochem Pharmacol. 1979 Apr 15;28(8):1431-3. doi: 10.1016/0006-2952(79)90449-0.
6
The roles of aldehyde metabolising enzymes in neurotransmitter metabolism.醛代谢酶在神经递质代谢中的作用。
Prog Clin Biol Res. 1982;114:307-17.
7
Nicotinamide adenine dinucleotide phosphate-decanaldehyde adduct as an inhibitor of beef brain NADP-linked aldehyde reductase.烟酰胺腺嘌呤二核苷酸磷酸 - 癸醛加合物作为牛肉脑烟酰胺腺嘌呤二核苷酸磷酸连接的醛还原酶的抑制剂。
J Med Chem. 1979 Aug;22(8):1011-4. doi: 10.1021/jm00194a026.
8
Enzymes of biogenic aldehyde metabolism.生物源醛代谢的酶类。
Adv Exp Med Biol. 1975;59:119-38. doi: 10.1007/978-1-4757-0632-1_10.
9
Inhibition of aldehyde reductase isoenzymes in human and rat brain.人及大鼠大脑中醛还原酶同工酶的抑制作用
Biochem Pharmacol. 1975 Oct 15;24(20):1865-9. doi: 10.1016/0006-2952(75)90405-0.
10
Metabolism of aldehydes in brain.大脑中醛类的代谢
Essays Neurochem Neuropharmacol. 1977;1:103-38.
引用本文的文献
1
Nicotine Degradation by : Insights from Diverse Environmental Stressors and Wastewater Medium.尼古丁降解：来自不同环境应激源和废水介质的见解
Molecules. 2025 Jun 19;30(12):2658. doi: 10.3390/molecules30122658.
2
Attachment of Hydrogel Patches to Eye Tissue through Gel Transfer using Flexible Foils.通过使用柔性箔片进行凝胶转移将水凝胶贴片附着到眼部组织上。
ACS Appl Mater Interfaces. 2025 Feb 12;17(6):8849-8861. doi: 10.1021/acsami.4c15089. Epub 2025 Jan 28.
3
Advances in Induced Pluripotent Stem Cell-Derived Natural Killer Cell Therapy.诱导多能干细胞来源的自然杀伤细胞疗法的进展
Cells. 2024 Nov 29;13(23):1976. doi: 10.3390/cells13231976.
4
Unravelling the molecular basis of PARP inhibitor resistance in prostate cancer with homologous recombination repair deficiency.解析同源重组修复缺陷型前列腺癌中聚腺苷二磷酸核糖聚合酶抑制剂耐药的分子基础。
Int Rev Cell Mol Biol. 2024;389:257-301. doi: 10.1016/bs.ircmb.2024.03.004. Epub 2024 Mar 31.
5
A Rare Case of a Medial Peritalar Dislocation on a Rock Climber.一名攀岩者发生距骨内侧脱位的罕见病例。
J Orthop Case Rep. 2024 Sep;14(9):24-29. doi: 10.13107/jocr.2024.v14.i09.4716.
6
AARS and CACNA1A mutations: diagnostic insights into a case report of uncommon epileptic encephalopathy phenotypes in two siblings.AARS和CACNA1A突变：对两例罕见癫痫性脑病表型的同胞病例报告的诊断见解
Front Neurol. 2024 Apr 15;15:1376643. doi: 10.3389/fneur.2024.1376643. eCollection 2024.
7
Anesthetic Considerations of Organ Procurement After Brain and Cardiac Death: A Narrative Review.脑死亡和心脏死亡后器官获取的麻醉考量：一篇叙述性综述
Cureus. 2023 Jun 19;15(6):e40629. doi: 10.7759/cureus.40629. eCollection 2023 Jun.
8
Statins in Chronic Kidney Disease-Effects on Atherosclerosis and Cellular Senescence.他汀类药物在慢性肾脏病中的作用——对动脉粥样硬化和细胞衰老的影响。
Cells. 2023 Jun 21;12(13):1679. doi: 10.3390/cells12131679.
9
Subtalar dislocations: Mechanisms, clinical presentation and methods of reduction.距下关节脱位：机制、临床表现及复位方法。
World J Orthop. 2023 Jun 18;14(6):379-386. doi: 10.5312/wjo.v14.i6.379.
10
Hemodynamic management in brain dead donors.脑死亡供体的血流动力学管理
World J Transplant. 2021 Oct 18;11(10):410-420. doi: 10.5500/wjt.v11.i10.410.
本文引用的文献
1
Preventing overdiagnosis: how to stop harming the healthy.预防过度诊断：如何避免伤害健康者。
BMJ. 2012 May 28;344:e3502. doi: 10.1136/bmj.e3502.
2
Outcomes in 125 individuals with adrenal incidentalomas from a single centre. a retrospective assessment of the 1 mg overnight and low dose dexamethasone suppression tests.125 例单一中心肾上腺意外瘤患者的结果。对 1mg 过夜和小剂量地塞米松抑制试验的回顾性评估。
Horm Metab Res. 2011 Dec;43(13):962-9. doi: 10.1055/s-0031-1291249. Epub 2011 Nov 2.
3
Cohort study of patients with adrenal lesions discovered incidentally.偶然发现的肾上腺病变患者的队列研究。
Br J Surg. 2011 Oct;98(10):1383-91. doi: 10.1002/bjs.7566. Epub 2011 May 27.
4
Low investigation rate for adrenal incidentalomas.肾上腺意外瘤的调查率较低。
Endocrine. 2011 Aug;40(1):134-6. doi: 10.1007/s12020-011-9487-9. Epub 2011 May 12.
5
The prevalence of adrenal incidentaloma in routine clinical practice.在常规临床实践中，肾上腺意外瘤的患病率。
Endocrine. 2011 Aug;40(1):80-3. doi: 10.1007/s12020-011-9445-6. Epub 2011 Mar 10.
6
Approach to the patient with an adrenal incidentaloma.肾上腺意外瘤患者的处理方法。
J Clin Endocrinol Metab. 2010 Sep;95(9):4106-13. doi: 10.1210/jc.2010-0457.
7
Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience.肾上腺意外瘤：临床、代谢、随访方面：单中心经验。
Endocrine. 2010 Feb;37(1):40-6. doi: 10.1007/s12020-009-9260-5. Epub 2009 Oct 30.
8
The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas.美国临床内分泌医师协会和美国内分泌外科医师协会关于肾上腺偶发瘤管理的医学指南。
Endocr Pract. 2009 Jul-Aug;15 Suppl 1:1-20. doi: 10.4158/EP.15.S1.1.
9
Adrenal incidentalomas, 2003 to 2005: experience after publication of the National Institutes of Health consensus statement.2003年至2005年的肾上腺偶发瘤：美国国立卫生研究院共识声明发布后的经验
Endocr Pract. 2008 Apr;14(3):279-84. doi: 10.4158/EP.14.3.279.
10
Clinical practice. The incidentally discovered adrenal mass.临床实践。偶然发现的肾上腺肿块。
N Engl J Med. 2007 Feb 8;356(6):601-10. doi: 10.1056/NEJMcp065470.
Zotero 插件